Hollister-Stier Laboratories (TwinJect Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
2
Hollister-Stier Laboratories (TwinJect Rights) General Information
Description
An emergency supportive therapy used for the treatment of severe allergic reactions and anaphylaxis.The product is designed as an emergency supportive therapy for immediate treatment of Anaphylaxis which is a sudden, severe, and potentially life-threatening allergic reaction triggered by exposure to one or more allergens, including foods, insect stings, drugs, and latex products and is indicated in the emergency treatment of this severe allergic reaction.
Contact Information
Corporate Office
- Spokane, WA
- United States
Corporate Office
- Spokane, WA
- United States
Hollister-Stier Laboratories (TwinJect Rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hollister-Stier Laboratories (TwinJect Rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hollister-Stier Laboratories (TwinJect Rights) FAQs
-
Where is Hollister-Stier Laboratories (TwinJect Rights) headquartered?
Hollister-Stier Laboratories (TwinJect Rights) is headquartered in Spokane, WA.
-
What industry is Hollister-Stier Laboratories (TwinJect Rights) in?
Hollister-Stier Laboratories (TwinJect Rights)’s primary industry is Buildings and Property.
-
Is Hollister-Stier Laboratories (TwinJect Rights) a private or public company?
Hollister-Stier Laboratories (TwinJect Rights) is a Private company.
-
What is the current valuation of Hollister-Stier Laboratories (TwinJect Rights)?
The current valuation of Hollister-Stier Laboratories (TwinJect Rights) is .
-
What is Hollister-Stier Laboratories (TwinJect Rights)’s current revenue?
The current revenue for Hollister-Stier Laboratories (TwinJect Rights) is .
-
Who are Hollister-Stier Laboratories (TwinJect Rights)’s investors?
HollisterStier Allergy, Verus Pharmaceuticals, and Windward Capital Advisors have invested in Hollister-Stier Laboratories (TwinJect Rights).
-
When was Hollister-Stier Laboratories (TwinJect Rights) acquired?
Hollister-Stier Laboratories (TwinJect Rights) was acquired on 13-Mar-2008.
-
Who acquired Hollister-Stier Laboratories (TwinJect Rights)?
Hollister-Stier Laboratories (TwinJect Rights) was acquired by Sciele Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process